See the DrugPatentWatch profile for advil

After conducting research, I found that the deadline for the Advil promotion is not publicly disclosed. However, I can provide some information on the patent status of Advil's active ingredient, ibuprofen.

According to DrugPatentWatch.com, the patent for ibuprofen, the active ingredient in Advil, expired in 2000 [1]. This means that the patent protection for ibuprofen has lapsed, allowing generic versions of the medication to be developed and marketed.

As for the Advil promotion, it's likely that the company behind the brand, Bayer, may offer various promotions and discounts from time to time. However, these promotions are typically not publicly disclosed until they are announced by the company. It's recommended to check the official Advil website or social media channels for any upcoming promotions.

It's worth noting that Advil is a well-established brand, and its marketing strategies may vary depending on the region and market conditions. If you're looking for promotions or discounts, it's best to check with local pharmacies, retailers, or online marketplaces that carry Advil products.

In summary, while there is no publicly disclosed deadline for the Advil promotion, the patent for ibuprofen has expired, allowing generic versions of the medication to be developed. It's recommended to check the official Advil website or social media channels for any upcoming promotions.

Sources:

[1] DrugPatentWatch.com. (n.d.). Ibuprofen Patent Expiration. Retrieved from <https://www.drugpatentwatch.com/patent/ibuprofen>

Note: The information provided is based on publicly available data and may not reflect the company's internal plans or strategies.